News | April 29, 2025
Vimta Labs to invest Rs. 50 crores to Biologics CDMO business foray
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
The foray into this new segment will help Vimta to enter into the growing CDMO business of biologics and peptides
Before joining Sun Pharma, Tulla served as Senior Vice President and Chief Commercial Head – Acute Cluster at Cipla
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
Asahi Kasei Life Science covers a broad range of bioprocess products and services
The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Subscribe To Our Newsletter & Stay Updated
